Anebulo Pharmaceuticals, Inc. (ANEB)

USD 1.15

(-2.54%)

Net Income Summary of Anebulo Pharmaceuticals, Inc.

  • Anebulo Pharmaceuticals, Inc.'s latest annual net income in 2024 was -8.2 Million USD , up 30.09% from previous year.
  • Anebulo Pharmaceuticals, Inc.'s latest quarterly net income in 2024 Q4 was -1.34 Million USD , up 18.36% from previous quarter.
  • Anebulo Pharmaceuticals, Inc. reported an annual net income of -11.73 Million USD in 2023, down -72.21% from previous year.
  • Anebulo Pharmaceuticals, Inc. reported an annual net income of -6.81 Million USD in 2022, up 77.49% from previous year.
  • Anebulo Pharmaceuticals, Inc. reported a quarterly net income of -1.65 Million USD for 2024 Q3, up 39.15% from previous quarter.
  • Anebulo Pharmaceuticals, Inc. reported a quarterly net income of -1.34 Million USD for 2024 Q4, up 18.36% from previous quarter.

Annual Net Income Chart of Anebulo Pharmaceuticals, Inc. (2024 - 2020)

Historical Annual Net Income of Anebulo Pharmaceuticals, Inc. (2024 - 2020)

Year Net Income Net Income Growth
2024 -8.2 Million USD 30.09%
2023 -11.73 Million USD -72.21%
2022 -6.81 Million USD 77.49%
2021 -30.26 Million USD -17229.26%
2020 -174.63 Thousand USD 0.0%

Peer Net Income Comparison of Anebulo Pharmaceuticals, Inc.

Name Net Income Net Income Difference
Sangamo Therapeutics, Inc. -257.83 Million USD 96.819%
IDEAYA Biosciences, Inc. -112.96 Million USD 92.739%
Eton Pharmaceuticals, Inc. -936 Thousand USD -776.25%
Autolus Therapeutics plc -208.38 Million USD 96.064%
Greenwich LifeSciences, Inc. -8.89 Million USD 7.761%
Enlivex Therapeutics Ltd. -29.06 Million USD 71.784%
Shattuck Labs, Inc. -87.29 Million USD 90.605%
LENZ Therapeutics, Inc. -124.65 Million USD 93.42%
CervoMed Inc. -2.17 Million USD -277.633%
Rocket Pharmaceuticals, Inc. -245.59 Million USD 96.66%
Corbus Pharmaceuticals Holdings, Inc. -44.6 Million USD 81.612%
Aptose Biosciences Inc. -51.2 Million USD 83.983%
Precision BioSciences, Inc. -61.31 Million USD 86.625%
Dyadic International, Inc. -6.79 Million USD -20.694%
TScan Therapeutics, Inc. -89.21 Million USD 90.807%
Intensity Therapeutics, Inc. -10.53 Million USD 22.17%
Nektar Therapeutics -276.05 Million USD 97.029%
CytomX Therapeutics, Inc. -569 Thousand USD -1341.424%
VYNE Therapeutics Inc. -28.45 Million USD 71.174%
EyePoint Pharmaceuticals, Inc. -70.79 Million USD 88.415%
Leap Therapeutics, Inc. -81.41 Million USD 89.926%
Adaptive Biotechnologies Corporation -225.25 Million USD 96.359%
GRI Bio, Inc. -13.03 Million USD 37.089%
Xenetic Biosciences, Inc. -4.13 Million USD -98.369%
Tenaya Therapeutics, Inc. -124.08 Million USD 93.39%
NeuroSense Therapeutics Ltd. -10.1 Million USD 18.851%
Psyence Biomedical Ltd. -51.15 Million USD 83.968%
IGM Biosciences, Inc. -246.41 Million USD 96.672%
INmune Bio, Inc. -30 Million USD 72.668%
Opthea Limited -220.24 Million USD 96.276%
Milestone Pharmaceuticals Inc. -59.68 Million USD 86.258%
Omega Therapeutics, Inc. -97.42 Million USD 91.582%
Verastem, Inc. -87.36 Million USD 90.612%
Abeona Therapeutics Inc. -54.18 Million USD 84.864%
Pliant Therapeutics, Inc. -161.33 Million USD 94.916%
Tonix Pharmaceuticals Holding Corp. -116.65 Million USD 92.969%
Ligand Pharmaceuticals Incorporated 52.15 Million USD 115.726%
NextCure, Inc. -62.72 Million USD 86.924%
Inhibikase Therapeutics, Inc. -19.02 Million USD 56.899%
Organovo Holdings, Inc. -14.67 Million USD 44.096%
Lixte Biotechnology Holdings, Inc. -5.08 Million USD -61.228%
Arvinas, Inc. -367.3 Million USD 97.767%
Ovid Therapeutics Inc. -52.33 Million USD 84.33%
CASI Pharmaceuticals, Inc. -26.93 Million USD 69.553%
Rani Therapeutics Holdings, Inc. -33.97 Million USD 75.856%
Centessa Pharmaceuticals plc -151.08 Million USD 94.571%
Arcturus Therapeutics Holdings Inc. -29.72 Million USD 72.408%
Syros Pharmaceuticals, Inc. -164.57 Million USD 95.016%
Senti Biosciences, Inc. -92.91 Million USD 91.173%
BioRestorative Therapies, Inc. -10.41 Million USD 21.271%
Apollomics, Inc. -172.6 Million USD 95.248%
PureTech Health plc -65.69 Million USD 87.516%
Oncternal Therapeutics, Inc. -39.47 Million USD 79.225%
Barinthus Biotherapeutics plc -73.34 Million USD 88.818%
Kymera Therapeutics, Inc. -146.96 Million USD 94.419%
Synaptogenix, Inc. -6.03 Million USD -35.823%
ChromaDex Corporation -4.93 Million USD -66.094%
Beam Therapeutics Inc. -132.52 Million USD 93.811%
Monopar Therapeutics Inc. -8.4 Million USD 2.386%
Akebia Therapeutics, Inc. -51.92 Million USD 84.205%
Nurix Therapeutics, Inc. -143.94 Million USD 94.302%
Apellis Pharmaceuticals, Inc. -528.62 Million USD 98.448%
Dermata Therapeutics, Inc. -7.79 Million USD -5.222%
Gritstone bio, Inc. -138.49 Million USD 94.078%
Mesoblast Limited -87.95 Million USD 90.675%
Virpax Pharmaceuticals, Inc. -15.18 Million USD 46.004%
Xeris Biopharma Holdings, Inc. -62.25 Million USD 86.826%
Fate Therapeutics, Inc. -160.92 Million USD 94.903%
MediWound Ltd. -6.71 Million USD -22.122%
BioXcel Therapeutics, Inc. -179.05 Million USD 95.419%
Fortress Biotech, Inc. -60.63 Million USD 86.474%
Fractyl Health, Inc. Common Stock -77.09 Million USD 89.361%
Achilles Therapeutics plc -69.66 Million USD 88.227%
Seres Therapeutics, Inc. -113.72 Million USD 92.788%
Checkpoint Therapeutics, Inc. -51.84 Million USD 84.181%
Atossa Therapeutics, Inc. -30.09 Million USD 72.746%
Zai Lab Limited -334.62 Million USD 97.549%
Fresh Tracks Therapeutics, Inc. -5.69 Million USD -44.041%
Lyell Immunopharma, Inc. -234.63 Million USD 96.504%
Vanda Pharmaceuticals Inc. 2.5 Million USD 426.891%
Tarsus Pharmaceuticals, Inc. -135.89 Million USD 93.965%
InMed Pharmaceuticals Inc. -7.67 Million USD -6.855%
FibroGen, Inc. -284.23 Million USD 97.114%
Celcuity Inc. -63.77 Million USD 87.14%
SeaStar Medical Holding Corporation -26.23 Million USD 68.734%
ContextLogic Inc. -317 Million USD 97.413%
GH Research PLC -35.58 Million USD 76.953%
HOOKIPA Pharma Inc. -81.58 Million USD 89.946%
Cyclacel Pharmaceuticals, Inc. -22.55 Million USD 63.637%
ImmuCell Corporation -5.77 Million USD -42.031%
Amylyx Pharmaceuticals, Inc. 49.27 Million USD 116.646%
Amarin Corporation plc -59.11 Million USD 86.125%
TG Therapeutics, Inc. 12.67 Million USD 164.723%
Aptevo Therapeutics Inc. -17.41 Million USD 52.894%
Jasper Therapeutics, Inc. -64.46 Million USD 87.277%
Foghorn Therapeutics Inc. -98.42 Million USD 91.667%
Y-mAbs Therapeutics, Inc. -21.42 Million USD 61.723%
Aptorum Group Limited -2.82 Million USD -190.362%
Ultragenyx Pharmaceutical Inc. -606.63 Million USD 98.648%
BioCryst Pharmaceuticals, Inc. -226.53 Million USD 96.38%
Chemomab Therapeutics Ltd. -24.22 Million USD 66.138%
Arrowhead Pharmaceuticals, Inc. -205.27 Million USD 96.005%
TransCode Therapeutics, Inc. -18.54 Million USD 55.777%
RAPT Therapeutics, Inc. -116.79 Million USD 92.978%
Ardelyx, Inc. -66.06 Million USD 87.586%
Ainos, Inc. -13.77 Million USD 40.44%
Lyra Therapeutics, Inc. -62.68 Million USD 86.915%
Prothena Corporation plc -147.02 Million USD 94.422%
HilleVax, Inc. -123.56 Million USD 93.362%
Adaptimmune Therapeutics plc -113.87 Million USD 92.797%
Celularity Inc. -196.29 Million USD 95.822%
Rallybio Corporation -74.56 Million USD 89.0%
Cue Biopharma, Inc. -50.73 Million USD 83.834%
Omeros Corporation -117.81 Million USD 93.038%
Humacyte, Inc. -110.77 Million USD 92.596%
Immunocore Holdings plc -55.28 Million USD 85.165%
Cocrystal Pharma, Inc. -17.98 Million USD 54.394%
Blueprint Medicines Corporation -506.98 Million USD 98.382%
IO Biotech, Inc. -86.08 Million USD 90.472%
MEI Pharma, Inc. 17.77 Million USD 146.134%
GT Biopharma, Inc. -7.59 Million USD -7.96%
Cabaletta Bio, Inc. -67.67 Million USD 87.881%
Summit Therapeutics Inc. -614.92 Million USD 98.666%
Alaunos Therapeutics, Inc. -35.14 Million USD 76.66%
Marinus Pharmaceuticals, Inc. -141.4 Million USD 94.2%
Scholar Rock Holding Corporation -165.78 Million USD 95.053%
Pulmatrix, Inc. -14.12 Million USD 41.918%
Elicio Therapeutics, Inc. -35.19 Million USD 76.696%
X4 Pharmaceuticals, Inc. -101.16 Million USD 91.893%
Vigil Neuroscience, Inc. -82.63 Million USD 90.075%
Acelyrin, Inc. -381.64 Million USD 97.851%
Intellia Therapeutics, Inc. -481.19 Million USD 98.296%
Cytokinetics, Incorporated -526.24 Million USD 98.441%
Vor Biopharma Inc. -117.86 Million USD 93.041%
Evogene Ltd. -23.87 Million USD 65.653%
Replimune Group, Inc. -215.79 Million USD 96.199%
Applied Therapeutics, Inc. -119.76 Million USD 93.152%
PDS Biotechnology Corporation -42.94 Million USD 80.901%
Hoth Therapeutics, Inc. -7.84 Million USD -4.542%
BridgeBio Pharma, Inc. -643.2 Million USD 98.725%
AEON Biopharma, Inc. -52.55 Million USD 84.394%
BioLineRx Ltd. -60.61 Million USD 86.469%
Galectin Therapeutics Inc. -41.06 Million USD 80.028%
Atai Life Sciences N.V. -40.22 Million USD 79.61%
Aerovate Therapeutics, Inc. -75.52 Million USD 89.14%
VistaGen Therapeutics, Inc. -29.36 Million USD 72.067%
Zentalis Pharmaceuticals, Inc. -292.19 Million USD 97.193%
Sagimet Biosciences Inc. -27.87 Million USD 70.578%
MediciNova, Inc. -8.57 Million USD 4.314%
Praxis Precision Medicines, Inc. -123.27 Million USD 93.347%
MiMedx Group, Inc. 67.43 Million USD 112.162%
Cardio Diagnostics Holdings, Inc. -8.37 Million USD 2.091%
Axsome Therapeutics, Inc. -239.23 Million USD 96.572%
PTC Therapeutics, Inc. -626.6 Million USD 98.691%
Mereo BioPharma Group plc -29.46 Million USD 72.166%
Syndax Pharmaceuticals, Inc. -209.36 Million USD 96.082%
NRx Pharmaceuticals, Inc. -30.15 Million USD 72.797%
Dyne Therapeutics, Inc. -235.93 Million USD 96.524%
BriaCell Therapeutics Corp. -4.79 Million USD -71.173%
Allakos Inc. -185.7 Million USD 95.583%
scPharmaceuticals Inc. -54.81 Million USD 85.036%
Fulcrum Therapeutics, Inc. -97.33 Million USD 91.574%
Corcept Therapeutics Incorporated 106.14 Million USD 107.727%
NLS Pharmaceutics AG -12.17 Million USD 32.618%
Precigen, Inc. -95.9 Million USD 91.448%
XOMA Corporation -40.83 Million USD 79.913%
Kezar Life Sciences, Inc. -101.87 Million USD 91.949%
Incyte Corporation 597.59 Million USD 101.372%
Alzamend Neuro, Inc. -9.94 Million USD 17.552%
Cara Therapeutics, Inc. -118.51 Million USD 93.079%
Aligos Therapeutics, Inc. -87.67 Million USD 90.646%
Seer, Inc. -86.27 Million USD 90.494%
Reviva Pharmaceuticals Holdings, Inc. -24.33 Million USD 66.303%
CRISPR Therapeutics AG -153.61 Million USD 94.661%
Akero Therapeutics, Inc. -151.75 Million USD 94.596%
Eliem Therapeutics, Inc. -35.11 Million USD 76.646%
EyeGate Pharmaceuticals, Inc. -8.09 Million USD -1.356%
Akari Therapeutics, Plc -10 Million USD 18.049%
Novavax, Inc. -545.06 Million USD 98.495%
Lexaria Bioscience Corp. -6.66 Million USD -23.058%
UroGen Pharma Ltd. -102.24 Million USD 91.978%
Sutro Biopharma, Inc. -106.79 Million USD 92.32%
Entera Bio Ltd. -8.88 Million USD 7.732%
Lisata Therapeutics, Inc. -20.84 Million USD 60.644%
Stoke Therapeutics, Inc. -104.69 Million USD 92.166%
Chimerix, Inc. -82.09 Million USD 90.009%
Reneo Pharmaceuticals, Inc. -77.38 Million USD 89.402%
Phathom Pharmaceuticals, Inc. -201.59 Million USD 95.932%
Outlook Therapeutics, Inc. -58.98 Million USD 86.095%
Jazz Pharmaceuticals plc 414.83 Million USD 101.977%
AnaptysBio, Inc. -163.61 Million USD 94.987%
Aprea Therapeutics, Inc. -14.28 Million USD 42.592%
Portage Biotech Inc. -75.33 Million USD 89.114%
Olema Pharmaceuticals, Inc. -96.65 Million USD 91.514%
PMV Pharmaceuticals, Inc. -68.96 Million USD 88.107%
OKYO Pharma Limited -16.82 Thousand USD -48645.788%
Qualigen Therapeutics, Inc. -13.41 Million USD 38.872%
Cadrenal Therapeutics, Inc. Common Stock -8.35 Million USD 1.859%
Processa Pharmaceuticals, Inc. -11.12 Million USD 26.254%
AbCellera Biologics Inc. -146.39 Million USD 94.398%
Genprex, Inc. -30.86 Million USD 73.423%
Neumora Therapeutics, Inc. Common Stock -235.92 Million USD 96.524%
NLS Pharmaceutics AG -12.17 Million USD 32.618%
Virios Therapeutics, Inc. -5.29 Million USD -54.866%
Daré Bioscience, Inc. -30.16 Million USD 72.807%
Titan Pharmaceuticals, Inc. -5.56 Million USD -47.274%
Bicycle Therapeutics plc -180.66 Million USD 95.46%
Revolution Medicines, Inc. Warrant -436.36 Million USD 98.12%
Protagonist Therapeutics, Inc. -78.95 Million USD 89.612%
Erasca, Inc. -125.04 Million USD 93.441%
bluebird bio, Inc. -211.91 Million USD 96.13%
Pieris Pharmaceuticals, Inc. -24.54 Million USD 66.582%
BioMarin Pharmaceutical Inc. 167.64 Million USD 104.892%
DBV Technologies S.A. -72.72 Million USD 88.722%
Fortress Biotech, Inc. -60.63 Million USD 86.474%
Avidity Biosciences, Inc. -212.22 Million USD 96.135%
CorMedix Inc. -46.33 Million USD 82.301%
Travere Therapeutics, Inc. -111.39 Million USD 92.638%
Sensei Biotherapeutics, Inc. -34.1 Million USD 75.949%
Orchestra BioMed Holdings, Inc. -49.12 Million USD 83.303%
Spruce Biosciences, Inc. -47.91 Million USD 82.884%
Celldex Therapeutics, Inc. -141.42 Million USD 94.201%
Cartesian Therapeutics, Inc. -219.71 Million USD 96.267%
Cogent Biosciences, Inc. -192.41 Million USD 95.737%
Onconetix, Inc. -37.4 Million USD 78.076%
Ocuphire Pharma, Inc. -9.98 Million USD 17.868%
Prime Medicine, Inc. -198.13 Million USD 95.861%
Adagene Inc. -18.94 Million USD 56.711%
Inhibrx Biosciences, Inc. -241.36 Million USD 96.602%
GlycoMimetics, Inc. -36.89 Million USD 77.773%
Maravai LifeSciences Holdings, Inc. -119.02 Million USD 93.109%
Verve Therapeutics, Inc. -200.06 Million USD 95.901%
Voyager Therapeutics, Inc. 132.33 Million USD 106.198%
SciSparc Ltd. -5.12 Million USD -60.127%
Revelation Biosciences, Inc. -120.25 Thousand USD -6720.316%
Minerva Neurosciences, Inc. -30 Million USD 72.666%
Astria Therapeutics, Inc. -72.89 Million USD 88.748%
Spero Therapeutics, Inc. 22.8 Million USD 135.963%
Tevogen Bio Holdings Inc. -67.32 Thousand USD -12082.255%
Arcutis Biotherapeutics, Inc. -262.14 Million USD 96.871%
Marker Therapeutics, Inc. -14.04 Million USD 41.608%
Alnylam Pharmaceuticals, Inc. -440.24 Million USD 98.137%
Artelo Biosciences, Inc. -9.87 Million USD 16.936%
2seventy bio, Inc. -217.57 Million USD 96.23%
ADMA Biologics, Inc. -28.23 Million USD 70.956%
Clene Inc. -49.5 Million USD 83.432%
Capricor Therapeutics, Inc. -22.28 Million USD 63.201%
Boundless Bio, Inc. Common Stock -49.43 Million USD 83.409%
Recursion Pharmaceuticals, Inc. -328.06 Million USD 97.5%
Citius Pharmaceuticals, Inc. -32.54 Million USD 74.797%
Contineum Therapeutics, Inc. Class A Common Stock 22.72 Million USD 136.099%
Absci Corporation -110.56 Million USD 92.582%
Regeneron Pharmaceuticals, Inc. 3.95 Billion USD 100.207%
Surrozen, Inc. -43.04 Million USD 80.945%
Caribou Biosciences, Inc. -102.07 Million USD 91.965%
Janux Therapeutics, Inc. -58.29 Million USD 85.93%
Cingulate Inc. -23.53 Million USD 65.151%
Galmed Pharmaceuticals Ltd. -6.91 Million USD -18.659%
Tenax Therapeutics, Inc. -7.71 Million USD -6.368%
Jaguar Health, Inc. -41.3 Million USD 80.141%
Terns Pharmaceuticals, Inc. -90.21 Million USD 90.908%
ACADIA Pharmaceuticals Inc. -61.28 Million USD 86.617%
Kronos Bio, Inc. -112.67 Million USD 92.721%
Innoviva, Inc. 179.72 Million USD 104.564%
Bolt Biotherapeutics, Inc. -69.19 Million USD 88.147%
Entrada Therapeutics, Inc. -6.68 Million USD -22.688%
ZyVersa Therapeutics, Inc. -98.29 Million USD 91.656%
Soligenix, Inc. -6.14 Million USD -33.562%
AlloVir, Inc. -190.41 Million USD 95.693%
Century Therapeutics, Inc. -136.67 Million USD 93.999%
ORIC Pharmaceuticals, Inc. -100.69 Million USD 91.855%
Kura Oncology, Inc. -152.63 Million USD 94.626%
Ocean Biomedical, Inc. 565.47 Thousand USD 1550.422%
Mineralys Therapeutics, Inc. -71.89 Million USD 88.593%
Eterna Therapeutics Inc. -21.66 Million USD 62.148%
SELLAS Life Sciences Group, Inc. -37.34 Million USD 78.035%
Heron Therapeutics, Inc. -110.55 Million USD 92.582%
SAB Biotherapeutics, Inc. -42.19 Million USD 80.562%
Pasithea Therapeutics Corp. -15.96 Million USD 48.616%
Entero Therapeutics, Inc. -15.79 Million USD 48.074%
HCW Biologics Inc. -24.99 Million USD 67.186%
C4 Therapeutics, Inc. -132.49 Million USD 93.81%
Atara Biotherapeutics, Inc. -276.12 Million USD 97.03%
Coherus BioSciences, Inc. -237.89 Million USD 96.552%
Lantern Pharma Inc. -15.96 Million USD 48.616%
Histogen Inc. -10.62 Million USD 22.778%
Surrozen, Inc. -43.04 Million USD 80.945%
Eledon Pharmaceuticals, Inc. -40.32 Million USD 79.662%
Kodiak Sciences Inc. -260.49 Million USD 96.851%
MoonLake Immunotherapeutics -36 Million USD 77.222%
Hepion Pharmaceuticals, Inc. -48.92 Million USD 83.237%
Adverum Biotechnologies, Inc. -117.16 Million USD 93.0%
Avalo Therapeutics, Inc. -31.54 Million USD 73.999%
Moderna, Inc. -4.71 Billion USD 99.826%
Ionis Pharmaceuticals, Inc. -366.28 Million USD 97.761%
Turnstone Biologics Corp. -55.2 Million USD 85.142%
Immix Biopharma, Inc. -15.42 Million USD 46.832%
Tiziana Life Sciences Ltd -16.2 Million USD 49.397%
Aurinia Pharmaceuticals Inc. -78.02 Million USD 89.488%
Exelixis, Inc. 207.76 Million USD 103.948%
Monte Rosa Therapeutics, Inc. -135.35 Million USD 93.94%
Wave Life Sciences Ltd. -57.51 Million USD 85.739%
Conduit Pharmaceuticals Inc. -535 Thousand USD -1433.029%
Alkermes plc 355.75 Million USD 102.305%
Jasper Therapeutics, Inc. -64.46 Million USD 87.277%
Arcellx, Inc. -70.69 Million USD 88.398%
ESSA Pharma Inc. -26.58 Million USD 69.146%
TNF Pharmaceuticals, Inc. -3.99 Million USD -105.045%
Avid Bioservices, Inc. -140.75 Million USD 94.173%
Insmed Incorporated -749.56 Million USD 98.906%
Cardiff Oncology, Inc. -41.44 Million USD 80.209%
Enanta Pharmaceuticals, Inc. -133.81 Million USD 93.871%
Moolec Science SA -51.78 Million USD 84.163%
RenovoRx, Inc. -10.23 Million USD 19.843%
Acumen Pharmaceuticals, Inc. -52.37 Million USD 84.339%
Geron Corporation -184.12 Million USD 95.546%
LAVA Therapeutics N.V. -41.97 Million USD 80.46%
Verrica Pharmaceuticals Inc. -66.99 Million USD 87.758%
Royalty Pharma plc 1.13 Billion USD 100.723%
OmniAb, Inc. -50.61 Million USD 83.797%
Alector, Inc. -130.39 Million USD 93.71%
Atea Pharmaceuticals, Inc. -135.95 Million USD 93.967%
Mersana Therapeutics, Inc. -171.67 Million USD 95.222%
Humacyte, Inc. -110.77 Million USD 92.596%
Structure Therapeutics Inc. -89.62 Million USD 90.848%
Revance Therapeutics, Inc. -323.98 Million USD 97.469%
89bio, Inc. -142.18 Million USD 94.232%
Avenue Therapeutics, Inc. -10.37 Million USD 20.963%
Aura Biosciences, Inc. -76.4 Million USD 89.266%
Immunic, Inc. -93.61 Million USD 91.239%
Veracyte, Inc. -74.4 Million USD 88.977%
Genelux Corporation -28.29 Million USD 71.016%
Trevi Therapeutics, Inc. -29.06 Million USD 71.782%
Adial Pharmaceuticals, Inc. -7 Million USD -17.136%
Sonnet BioTherapeutics Holdings, Inc. -18.83 Million USD 56.45%
Immunovant, Inc. -259.33 Million USD 96.837%
Vericel Corporation -3.18 Million USD -157.753%
Fortrea Holdings Inc. -3.4 Million USD -141.227%
KalVista Pharmaceuticals, Inc. -126.64 Million USD 93.524%
XBiotech Inc. -24.55 Million USD 66.601%
Agenus Inc. -245.76 Million USD 96.663%
Acasti Pharma Inc. -12.85 Million USD 36.188%
Kiora Pharmaceuticals, Inc. -12.51 Million USD 34.459%
MiNK Therapeutics, Inc. -22.45 Million USD 63.48%
Pasithea Therapeutics Corp. -15.96 Million USD 48.616%
Theravance Biopharma, Inc. -55.19 Million USD 85.14%
Metagenomi, Inc. Common Stock -68.25 Million USD 87.984%
NeuroBo Pharmaceuticals, Inc. -12.47 Million USD 34.229%
Gain Therapeutics, Inc. -22.26 Million USD 63.167%
Tempest Therapeutics, Inc. -29.49 Million USD 72.189%
Sol-Gel Technologies Ltd. -27.23 Million USD 69.889%
Rhythm Pharmaceuticals, Inc. -184.67 Million USD 95.559%
United Therapeutics Corporation 984.8 Million USD 100.833%
Creative Medical Technology Holdings, Inc. -5.28 Million USD -55.142%
BriaCell Therapeutics Corp. -4.79 Million USD -71.173%
Lixte Biotechnology Holdings, Inc. -5.08 Million USD -61.228%
Silo Pharma, Inc. -3.7 Million USD -121.627%
Telomir Pharmaceuticals, Inc. Common Stock -13.07 Million USD 37.257%
Pharming Group N.V. -10.54 Million USD 22.244%
XOMA Corporation -40.83 Million USD 79.913%
Reviva Pharmaceuticals Holdings, Inc. -24.33 Million USD 66.303%
Bionomics Limited -15.49 Billion USD 99.947%
Alpha Tau Medical Ltd. -29.15 Million USD 71.871%
Pyxis Oncology, Inc. -73.79 Million USD 88.885%
uniQure N.V. -308.47 Million USD 97.341%
Xilio Therapeutics, Inc. -76.4 Million USD 89.265%
Cassava Sciences, Inc. -97.21 Million USD 91.564%
60 Degrees Pharmaceuticals, Inc. -3.76 Million USD -117.8%
Windtree Therapeutics, Inc. -20.29 Million USD 59.58%
Poseida Therapeutics, Inc. -123.43 Million USD 93.355%
Pluri Inc. -20.88 Million USD 60.735%
MeiraGTx Holdings plc -84.02 Million USD 90.239%
Cidara Therapeutics, Inc. -22.93 Million USD 64.233%
ProMIS Neurosciences, Inc. -17.5 Million USD 53.15%
CalciMedica, Inc. -34.35 Million USD 76.128%
Sana Biotechnology, Inc. -283.25 Million USD 97.104%
Amicus Therapeutics, Inc. -151.58 Million USD 94.589%
Salarius Pharmaceuticals, Inc. -12.54 Thousand USD -65290.303%
Alpha Tau Medical Ltd. -29.15 Million USD 71.871%
Adlai Nortye Ltd. American Depositary Shares -104.87 Million USD 92.179%
Nutriband Inc. -5.48 Million USD -49.521%
Protara Therapeutics, Inc. -40.42 Million USD 79.709%
Compugen Ltd. -18.75 Million USD 56.267%
Roivant Sciences Ltd. 4.34 Billion USD 100.189%
ProKidney Corp. -35.46 Million USD 76.876%
Protagenic Therapeutics, Inc. -5 Million USD -64.018%
Elevai Labs, Inc. Common Stock -4.3 Million USD -90.67%
Tango Therapeutics, Inc. -101.74 Million USD 91.939%
Renovaro Biosciences Inc. -80.65 Million USD 89.831%
Zevra Therapeutics, Inc. -46.04 Million USD 82.189%
Benitec Biopharma Inc. -21.75 Million USD 62.293%
GeoVax Labs, Inc. -25.96 Million USD 68.415%
Biomea Fusion, Inc. -117.25 Million USD 93.005%
Cullinan Oncology, Inc. -153.16 Million USD 94.645%
4D Molecular Therapeutics, Inc. -100.83 Million USD 91.866%
Kiniksa Pharmaceuticals, Ltd. 14.08 Million USD 158.234%
Nuvectis Pharma, Inc. -22.26 Million USD 63.155%
Spyre Therapeutics, Inc. -338.79 Million USD 97.579%
Ventyx Biosciences, Inc. -192.96 Million USD 95.75%
Imunon, Inc. -19.51 Million USD 57.972%
BioAtla, Inc. -123.46 Million USD 93.357%
Allogene Therapeutics, Inc. -327.26 Million USD 97.494%
Larimar Therapeutics, Inc. -36.94 Million USD 77.803%
Zura Bio Limited -60.36 Million USD 86.412%
aTyr Pharma, Inc. -50.38 Million USD 83.723%
Madrigal Pharmaceuticals, Inc. -373.63 Million USD 97.805%
Viridian Therapeutics, Inc. -237.73 Million USD 96.55%
Galecto, Inc. -38.34 Million USD 78.613%
Tevogen Bio Holdings Inc. -67.32 Thousand USD -12082.255%
Halozyme Therapeutics, Inc. 281.59 Million USD 102.913%
Lexicon Pharmaceuticals, Inc. -177.11 Million USD 95.369%
PolyPid Ltd. -23.86 Million USD 65.633%
Aileron Therapeutics, Inc. -15.73 Million USD 47.866%
Forte Biosciences, Inc. -31.47 Million USD 73.943%
Xencor, Inc. -126.08 Million USD 93.495%
Coeptis Therapeutics Holdings, Inc. -21.26 Million USD 61.434%
Lexaria Bioscience Corp. -6.66 Million USD -23.058%
Instil Bio, Inc. -156.08 Million USD 94.745%
Cardio Diagnostics Holdings, Inc. -8.37 Million USD 2.091%
OncoCyte Corporation -27.78 Million USD 70.477%
Elevation Oncology, Inc. -45.7 Million USD 82.055%
Purple Biotech Ltd. -19.88 Million USD 58.744%
CollPlant Biotechnologies Ltd. -7.01 Million USD -16.85%
MacroGenics, Inc. -9.05 Million USD 9.453%
Verona Pharma plc -54.36 Million USD 84.915%
Tharimmune, Inc. -9.31 Million USD 11.99%
Apogee Therapeutics, Inc. -83.98 Million USD 90.234%
enGene Holdings Inc. Warrants -99.91 Million USD 91.791%
Aditxt, Inc. -32.38 Million USD 74.671%
XTL Biopharmaceuticals Ltd. -1.78 Million USD -360.253%
Savara Inc. -54.69 Million USD 85.005%
Curis, Inc. -47.41 Million USD 82.702%
Carmell Therapeutics Corporation -15.44 Million USD 46.898%
Achieve Life Sciences, Inc. -29.81 Million USD 72.491%
BeiGene, Ltd. -881.7 Million USD 99.07%
Protagenic Therapeutics, Inc. -5 Million USD -64.018%
Vincerx Pharma, Inc. -40.15 Million USD 79.576%
Plus Therapeutics, Inc. -13.31 Million USD 38.407%
Acrivon Therapeutics, Inc. Common Stock -60.38 Million USD 86.418%
Rigel Pharmaceuticals, Inc. -25.09 Million USD 67.312%
Adicet Bio, Inc. -142.65 Million USD 94.251%
Estrella Immunopharma, Inc. -7.31 Million USD -12.172%
Quantum-Si incorporated -95.96 Million USD 91.453%
Acurx Pharmaceuticals, Inc. -14.57 Million USD 43.738%
Generation Bio Co. -126.61 Million USD 93.522%
Black Diamond Therapeutics, Inc. -82.44 Million USD 90.052%
Invivyd, Inc. -198.64 Million USD 95.871%
Relay Therapeutics, Inc. -341.97 Million USD 97.602%
Quoin Pharmaceuticals, Ltd. -8.68 Million USD 5.582%
Moolec Science SA -51.78 Million USD 84.163%
Clearside Biomedical, Inc. -32.48 Million USD 74.752%
Longboard Pharmaceuticals, Inc. -54.42 Million USD 84.929%
Relmada Therapeutics, Inc. -98.79 Million USD 91.698%
ALX Oncology Holdings Inc. -160.8 Million USD 94.9%
Vir Biotechnology, Inc. -615.06 Million USD 98.667%
Evaxion Biotech A/S -22.12 Million USD 62.93%
Ocular Therapeutix, Inc. -80.73 Million USD 89.841%
Tyra Biosciences, Inc. -69.13 Million USD 88.137%
Unity Biotechnology, Inc. -39.86 Million USD 79.424%
Connect Biopharma Holdings Limited -59.5 Million USD 86.216%
Clearmind Medicine Inc. -11.95 Million USD 31.395%
Aadi Bioscience, Inc. -65.76 Million USD 87.529%
Catalyst Pharmaceuticals, Inc. 71.41 Million USD 111.485%
CERo Therapeutics Holdings, Inc. -2536.23 USD -323281.673%
Viking Therapeutics, Inc. -85.89 Million USD 90.451%
Keros Therapeutics, Inc. -152.99 Million USD 94.639%
Crinetics Pharmaceuticals, Inc. -214.52 Million USD 96.177%
ImmunityBio, Inc. -583.19 Million USD 98.594%
Korro Bio, Inc. -81.17 Million USD 89.896%
Kineta, Inc. -14.09 Million USD 41.828%
BioVie Inc. -32.12 Million USD 74.466%
Codexis, Inc. -76.24 Million USD 89.242%
Celularity Inc. -196.29 Million USD 95.822%
Virax Biolabs Group Limited -6.73 Million USD -21.804%
Cibus, Inc. -267.62 Million USD 96.935%
Annexon, Inc. -134.23 Million USD 93.89%
Assembly Biosciences, Inc. -61.22 Million USD 86.605%
Eyenovia, Inc. -27.26 Million USD 69.914%
Puma Biotechnology, Inc. 21.59 Million USD 137.987%
NeurAxis, Inc. -14.62 Million USD 43.926%
Regulus Therapeutics Inc. -30.03 Million USD 72.695%
Compass Therapeutics, Inc. -42.49 Million USD 80.699%
TFF Pharmaceuticals, Inc. -21.24 Million USD 61.391%
Notable Labs, Ltd. -11.26 Million USD 27.187%
IN8bio, Inc. -30 Million USD 72.667%
DiaMedica Therapeutics Inc. -19.38 Million USD 57.682%
Vera Therapeutics, Inc. -95.99 Million USD 91.456%
Lumos Pharma, Inc. -34.03 Million USD 75.901%
Liquidia Corporation -78.5 Million USD 89.552%
Mustang Bio, Inc. -51.6 Million USD 84.106%
Quantum-Si incorporated -95.96 Million USD 91.453%
Arbutus Biopharma Corporation -72.84 Million USD 88.742%
enGene Holdings Inc. Common Stock -99.91 Million USD 91.791%
ARS Pharmaceuticals, Inc. -54.36 Million USD 84.914%
180 Life Sciences Corp. -19.93 Million USD 58.858%
Vaxcyte, Inc. -402.26 Million USD 97.961%
Xenon Pharmaceuticals Inc. -182.39 Million USD 95.503%
Estrella Immunopharma, Inc. -7.31 Million USD -12.172%
NKGen Biotech, Inc. Warrants -82.95 Million USD 90.113%
Opiant Pharmaceuticals, Inc. 3 Million USD 372.591%
CERo Therapeutics Holdings, Inc. -2536.23 USD -323281.673%
Soleno Therapeutics, Inc. -38.98 Million USD 78.964%
PepGen Inc. -78.62 Million USD 89.569%
Moleculin Biotech, Inc. -29.76 Million USD 72.449%
Solid Biosciences Inc. -96.01 Million USD 91.458%
Palisade Bio, Inc. -12.3 Million USD 33.319%
Nutriband Inc. -5.48 Million USD -49.521%
Conduit Pharmaceuticals Inc. -535 Thousand USD -1433.029%
Immuneering Corporation -53.47 Million USD 84.662%
Belite Bio, Inc -31.63 Million USD 74.072%
CG Oncology, Inc. Common stock -48.6 Million USD 83.126%
GeoVax Labs, Inc. -25.96 Million USD 68.415%
Tourmaline Bio, Inc. -42.12 Million USD 80.53%
Altimmune, Inc. -88.44 Million USD 90.727%
Peak Bio, Inc. -1259.26 USD -651211.326%
SeaStar Medical Holding Corporation -26.23 Million USD 68.734%
FibroBiologics, Inc. Common Stock -16.48 Million USD 50.247%
Neurogene Inc. -36.31 Million USD 77.416%
Mirum Pharmaceuticals, Inc. -163.41 Million USD 94.981%
Kintara Therapeutics, Inc. -8.5 Million USD 3.521%
CARGO Therapeutics, Inc. Common Stock -98.14 Million USD 91.643%
Sesen Bio, Inc. -19.88 Million USD 58.752%
argenx SE -295.05 Million USD 97.22%
NKGen Biotech, Inc. Common Stock -82.95 Million USD 90.113%
Dianthus Therapeutics, Inc. -43.55 Million USD 81.169%
Immunome, Inc. -106.8 Million USD 92.321%
Enveric Biosciences, Inc. -17.29 Thousand USD -47331.362%
Design Therapeutics, Inc. -66.86 Million USD 87.733%
Seelos Therapeutics, Inc. -37.88 Million USD 78.349%
Enliven Therapeutics, Inc. -71.58 Million USD 88.543%
Iovance Biotherapeutics, Inc. -444.03 Million USD 98.153%
Taysha Gene Therapies, Inc. -111.56 Million USD 92.649%
Inovio Pharmaceuticals, Inc. -135.11 Million USD 93.93%
Athira Pharma, Inc. -117.67 Million USD 93.03%
XOMA Corporation -40.83 Million USD 79.913%
Merus N.V. -154.93 Million USD 94.706%
Quince Therapeutics, Inc. -31.38 Million USD 73.867%
Rezolute, Inc. -68.45 Million USD 88.02%
Clene Inc. -49.5 Million USD 83.432%
Indaptus Therapeutics, Inc. -15.42 Million USD 46.823%
BeyondSpring Inc. -21.02 Million USD 60.993%
Synlogic, Inc. -57.28 Million USD 85.682%
Allarity Therapeutics, Inc. -11.9 Million USD 31.084%
Phio Pharmaceuticals Corp. -10.82 Million USD 24.241%
Peak Bio, Inc. -1259.26 USD -651211.326%
Werewolf Therapeutics, Inc. -37.36 Million USD 78.052%
Krystal Biotech, Inc. 10.93 Million USD 175.025%
Karyopharm Therapeutics Inc. -143.09 Million USD 94.269%
SpringWorks Therapeutics, Inc. -325.1 Million USD 97.477%
Lipella Pharmaceuticals Inc. -4.61 Million USD -77.566%
MannKind Corporation -11.93 Million USD 31.298%
Ikena Oncology, Inc. -68.16 Million USD 87.968%
Cyclerion Therapeutics, Inc. -21.01 Million USD 60.972%
Gyre Therapeutics, Inc. -92.93 Million USD 91.175%
Gossamer Bio, Inc. -179.81 Million USD 95.439%
CohBar, Inc. -11.96 Million USD 31.436%
Cognition Therapeutics, Inc. -25.78 Million USD 68.196%
NRx Pharmaceuticals, Inc. -30.15 Million USD 72.797%
Legend Biotech Corporation -518.25 Million USD 98.417%
Mural Oncology plc -207.44 Million USD 96.046%
Disc Medicine, Inc. -76.42 Million USD 89.269%
Champions Oncology, Inc. -7.27 Million USD -12.723%
REGENXBIO Inc. -263.49 Million USD 96.887%
Ensysce Biosciences, Inc. -10.61 Million USD 22.721%
Anavex Life Sciences Corp. -47.5 Million USD 82.735%
Cellectar Biosciences, Inc. -37.98 Million USD 78.407%
Edgewise Therapeutics, Inc. -100.16 Million USD 91.812%
Vaxart, Inc. -82.46 Million USD 90.054%
PharmaCyte Biotech, Inc. 333.76 Thousand USD 2557.343%
Aldeyra Therapeutics, Inc. -37.54 Million USD 78.154%
Cellectis S.A. -101.05 Million USD 91.884%
Longeveron Inc. -21.41 Million USD 61.698%
Repare Therapeutics Inc. -93.79 Million USD 91.256%
Sarepta Therapeutics, Inc. -535.97 Million USD 98.47%
Inozyme Pharma, Inc. -71.16 Million USD 88.476%
Revolution Medicines, Inc. -436.36 Million USD 98.12%
Nymox Pharmaceutical Corporation -6.57 Million USD -24.817%
Third Harmonic Bio, Inc. -30.82 Million USD 73.392%
ArriVent BioPharma, Inc. Common Stock -69.33 Million USD 88.171%
AN2 Therapeutics, Inc. -64.73 Million USD 87.33%
Anixa Biosciences, Inc. -9.81 Million USD 16.403%
Vertex Pharmaceuticals Incorporated 3.61 Billion USD 100.227%
Denali Therapeutics Inc. -145.22 Million USD 94.352%
Revelation Biosciences, Inc. -120.25 Thousand USD -6720.316%
Veru Inc. -93.15 Million USD 91.195%
Corvus Pharmaceuticals, Inc. -27.02 Million USD 69.656%
Cingulate Inc. -23.53 Million USD 65.151%
Passage Bio, Inc. -102.06 Million USD 91.964%
Context Therapeutics Inc. -23.96 Million USD 65.775%
Exicure, Inc. -16.91 Million USD 51.509%
Day One Biopharmaceuticals, Inc. -188.91 Million USD 95.659%
Oramed Pharmaceuticals Inc. -37.76 Million USD 78.282%
Scinai Immunotherapeutics Ltd. -6.5 Million USD -26.038%
Nuvalent, Inc. -126.21 Million USD 93.502%
ABVC BioPharma, Inc. -10.51 Million USD 22.005%
Carisma Therapeutics, Inc. -86.87 Million USD 90.56%
Unicycive Therapeutics, Inc. -30.54 Million USD 73.148%
OmniAb, Inc. -50.61 Million USD 83.797%
Anew Medical, Inc. 1.34 Million USD 709.282%
Fennec Pharmaceuticals Inc. -16.04 Million USD 48.883%
Lipocine Inc. -16.35 Million USD 49.843%
Lexeo Therapeutics, Inc. Common Stock -66.39 Million USD 87.647%
Nautilus Biotechnology, Inc. -63.67 Million USD 87.119%
SAB Biotherapeutics, Inc. -42.19 Million USD 80.562%
G1 Therapeutics, Inc. -47.96 Million USD 82.901%
Bellerophon Therapeutics, Inc. -19.83 Million USD 58.642%
Sage Therapeutics, Inc. -541.48 Million USD 98.485%
Ocugen, Inc. -63.07 Million USD 86.998%
Mind Medicine (MindMed) Inc. -95.73 Million USD 91.433%
Q32 Bio Inc. -112.96 Million USD 92.739%
Brainstorm Cell Therapeutics Inc. -17.19 Million USD 52.293%
Alumis Inc. Common Stock -154.99 Million USD 94.708%
Equillium, Inc. -13.33 Million USD 38.495%
Kyverna Therapeutics, Inc. -60.36 Million USD 86.413%
Coya Therapeutics, Inc. -7.98 Million USD -2.677%
CNS Pharmaceuticals, Inc. -18.85 Million USD 56.492%
Dominari Holdings Inc. -22.88 Million USD 64.157%
Edesa Biotech, Inc. -8.37 Million USD 2.062%
vTv Therapeutics Inc. -20.25 Million USD 59.498%
Bio-Techne Corporation 168.1 Million USD 104.879%
Agios Pharmaceuticals, Inc. -352.08 Million USD 97.671%
Harmony Biosciences Holdings, Inc. 128.85 Million USD 106.365%
Prelude Therapeutics Incorporated -121.83 Million USD 93.268%
Candel Therapeutics, Inc. -37.93 Million USD 78.382%
iTeos Therapeutics, Inc. -112.64 Million USD 92.719%
Nkarta, Inc. -117.5 Million USD 93.02%
BioCardia, Inc. -11.57 Million USD 29.118%
Iterum Therapeutics plc -38.37 Million USD 78.625%